Purpose: Few studies looking for an effective biomarker to predict delirium have been performed. This study was designed to investigate whether a change in inflammatory status, indicated by blood natural killer (NK) cell activity, predicts delirium. Methods: This prospective study, performed in 4 university and 1 general hospital from September, 2011 to October, 2012, included 29 patients. Eligible patients were 65-89 years old, newly and emergently admitted. Patients were assessed daily, up to 7 days, for occurrence of DSM-IV-defined delirium. The main outcome measure was change in blood NK cell activity between the first and second mornings after admission. Results: The mean change in blood NK cell activity on the second morning, compared to the first morning, in patients developing delirium (n = 9) was significantly greater than that in patients without delirium (n = 20) (6.0% [SD 8.4] vs. −1.4% [9.0], respectively, t = 2.10, P = 0.045). Significant difference between the groups was still found after adjusting for age, the history of previous delirium, and the Clinical Dementia Rating score (F = 6.63, P = 0.017). Of note is that 8 of 9 (89%) patients developing delirium had increased blood NK cell activity, as did only 8 of 20 (40%) patients without delirium, giving measurement of this parameter, for distinguishing the two groups, a sensitivity of 89%, specificity 60%, positive predictive value 50%, negative predictive value 92%, positive likelihood ratio 2.22, and negative likelihood ratio 0.19. When combining this predictor with another predictor, a Delirium Rating Scale-Revised-98 severity score of 5 or more at baseline, positive and negative likelihood ratios were 7.80 and 0.24, respectively. Conclusion: Increase in blood NK cell activity may be associated with developing delirium. Further studies including larger numbers of patients are needed to justify the preventive use of drugs for patients meeting criteria for both predictors.
Introduction
Delirium is an acute change in cognition, with altered consciousness and impaired attention, that fluctuates over time (American Psychiatric Association, 2000) . Reportedly, its prevalence ranges from 11% to 33% on admission, and its incidence during the hospital stay ranges between 3% and 56% (Michaud et al., 2007) . With an increasingly aging population, delirium will increase further. Antipsychotics are widely used for treatment, but the side-effects are a cause for concern. Therefore, there is considerable interest regarding new approaches to the prevention and management of delirium. Although it is challenging to formulate etiopathogenic models that integrate risk factors already identified, it has been suggested that the neuroinflammatory pathway can be a major process underlying delirium when the individual is exposed to an acute systemic inflammatory condition, such as infection or after surgery (Cerejeira et al., 2010) . However, studies in humans in this field remain very scarce. Recently, blood levels of interleukin (IL)-6 and IL-8 or the β subunit of the S100 protein were reported to be higher in patients with delirium than in patients without delirium (van Munster et al., 2008 (van Munster et al., , 2010 . From a predictive point of view, a biomarker that changes prior to the onset of delirium is required. So far, three of the five studies of insulin-like growth factor 1 (IGF-1) in delirium indicate an association between IGF-1 and delirium occurrence (Adamis and Meagher, 2011) . We previously have reported increased IL-1β and decreased natural killer (NK) cell activity with the progress of agitation in patients with Alzheimer disease (Higuchi et al., 2010) , and now we have focused on these in the context of delirium prediction. While Adamis et al. (2007) did not recognize a relationship between delirium and blood IL-6, IL-1β or TNF-α, as biological markers, in elderly medical inpatients, the relationship between delirium and blood NK cell activity has not been investigated sufficiently. Due to the swift response of NK cells to inflammation, we hypothesized that a change in blood NK cell activity may predict developing delirium.
Methods
We examined the patients included in the DELIRIA-J (Delirium Intervention Research for Improving Acute phase outcomes in Japan) trial, in which preventive effects of ramelteon on delirium were examined (UMIN Clinical Trials Registry ID: UMIN000005591, URL www.umin. ac.jp/ctr/index-j.htm) (Hatta et al., in press ); For the purpose of current study, patients assigned to receive placebo (n = 34) were included and those assigned to receive ramelteon (n = 33) were not, as ramelteon appeared to have preventive effects on delirium.
Setting and participants
The study proceeded over a 14 month period (September 1, 2011 to October 31, 2012) in 4 university hospitals and 1 general hospital. All study protocols were approved by the institutional review board at each site, and written informed consent was obtained from patients or their substitute decision makers.
Eligible patients were 65-89 years old, newly admitted due to an emergency, and able to take medicine orally. Patients were admitted via emergency rooms to intensive care units or regular acute wards. At the time of admission, they were consecutively screened. Patients with delirium at the time of admission were not enrolled in the study. Patients were approached for enrollment purposes before the first night of admission. Patients were excluded from the study if they had an expected stay or life expectancy of less than 48 h.
The observation period was one week long, and we supposed that it would be difficult during that time to discriminate between delirium and the cognitive fluctuation of certain diseases, such as severe liver dysfunction and Lewy Body disease. Therefore, such diseases were excluded in advance. Lewy Body disease was excluded on the basis of prior diagnosis.
Withdrawal syndromes of alcohol dependency and drug abuse can include delirium, an etiology obviously different from delirium caused by systemic diseases. Patients with psychotic disorders or bipolar disorders are usually under treatment with antipsychotics, which may prevent the development of delirium. Therefore, such patients were also excluded.
During the study period, 1126 patients were assessed for eligibility, and 1059 patients were excluded. Of the 697 patients admitted to intensive care units, 658 were intubated or had a life expectancy of less than 48 h, and 306 out of 429 patients admitted to regular acute wards had an expected stay of less than 48 h. Diagnoses of severe liver dysfunction, Lewy Body disease, alcohol dependency, psychotic disorder, or bipolar disorder accounted for exclusion of 61 patients. Thus, 1025 patients did not meet inclusion criteria. In addition, 3 patients admitted to intensive care units and 31 patients admitted to regular acute wards refused to participate. Thus, 67 patients, consisting of 24 admitted to intensive care units and 43 admitted to regular acute wards, were included in the study. The 24 patients admitted to intensive care units stayed there for at least the first 3 days, during which blood samples were obtained. Thereafter, 1 patient was transferred to a regular acute ward. The rate of study participation among eligible patients was 66% (67/101). No patient withdrew consent. They were randomly assigned using the sealed envelope method to receive ramelteon (8 mg/day; n = 33) and placebo (n = 34). The number of patients discharged before day 7 was 13, but there were no discharges within 48 h after admission.
As ramelteon has preventive effects on delirium (Hatta et al., in press) , only patients assigned to receive placebo (n = 34) were included in the analysis. Delirium developed in 11 patients by day 7 from admission, but not in the remaining 23 patients. Blood samples could not be obtained in 2 patients who developed delirium on the first night. The timing of delirium occurrence in the remaining 9 patients was as follows: the second night, 1 patient; the third night, 4 patients; the fourth night, 1 patient; the fifth night, 1 patient; the sixth night, 2 patients. Also, we failed to obtain blood samples in 3 patients without delirium.
Assessment and measurement of blood indicators
Before starting the study, site-coordinators were trained as raters to assess outcomes. All site-coordinators were experienced psychiatrists. At the time of admission, baseline characteristics were collected. Also, results of the Acute Physiology and Chronic Health Evaluation (APACHE) II (APACHE II) (Knaus et al., 1985) , the Charlson Comorbidity Index (Charlson et al., 1987) , and the Eastern Cooperative Oncology Group Performance Status (Falkson et al., 1980) were recorded to indicate physical condition. The Clinical Dementia Rating (CDR) was used to evaluate the existence and severity of dementia (Hughes et al., 1982) . A family member who knew the patient before admission was interviewed for the CDR determination. The Delirium Rating Scale-Revised-98 (DRS-R98) was used to measure delirium symptoms (Trzepacz et al., 2010) . APACHE II, Performance Status, and DRS-R98 were performed daily up to 7 days. The DRS-R98 was measured between 10:00 and 11:00 AM. Once delirium occurred, the etiology according to the Delirium Etiology Rating Checklist was recorded (Trzepacz, 1999) . Delirium was defined according to the Diagnostic and Statistical Manual of Mental Disorder, text revision, 4th ed (American Psychiatric Association, 2000). The same person that diagnosed delirium using the DSM-IV-TR performed the rating scales assessments.
Blood NK cell activity was measured on the first and second mornings after admission. As mentioned in the Introduction, we have previously reported changes in inflammatory markers prior to the onset of agitation in patients with Alzheimer disease (Higuchi et al., 2010) . Therefore, we focused on these markers in the context of delirium prediction, and presumed that values of the markers on the second morning would have increased or decreased compared to those on the first morning after admission. Blood samples were obtained by cubital puncture at 6:00 AM before breakfast. NK cell activity was measured in a standard 4 h chromium (Cr) release assay, as previously described (Nakamura et al., 2003) . Production of IL-1β from peripheral monocytes was assessed by a high sensitivity enzyme-linked immunosorbent assay (ELISA), as described elsewhere (Baqui et al., 2000) . Briefly, after plasma was separated by centrifugation, monocytes were isolated by FicollHypaque gradient separation followed by overnight plastic adherence. Cultured monocytes were stimulated with LPS of either P. gingivalis or F. nucleatum for 2, 8, 24, and 48 h, and supernatant fluids were collected. IL-1β levels in supernatant fluids were determined by ELISA.
Data analysis
We assumed that blood NK cell activity or IL-1β would increase in 50% of patients without delirium and 85% of patients developing delirium, and that 25% of patients would develop delirium. The statistical power was set as power = 1-β = 80%, and sensitivity to α = 5% to be able to detect differences in the effects of delirium. Power analysis consequently set the required number of patients at 38 patients without delirium and 13 patients developing delirium. Thus, 51 patients in total were required for the study purpose. We closed study after 67 patients were enrolled (the ramelteon group, n = 33; the placebo group, n = 34), as 32 patients per group were required for the Deliria-J trial. In the present study, only the placebo group (n = 34) was included, which is 67% (34/51) of the required number of patients.
Data were collected on standardized forms and statistical analyses were performed using SPSS version 20-J software (SPSS, Tokyo, Japan). Differences between categorical variables in patient demographics and clinical characteristics were calculated using Fisher's exact test. Differences between sequential variables were calculated using the unpaired t test (with Welch correction if applicable). If data were not sampled from Gaussian distributions, a non-parametric test (Mann-Whitney test) was used. To control for the effect of age, the history of previous delirium, and the CDR score on the change in NK cell activity or IL-1β, one-way analysis of covariance was used. We examined the predictive value of the DRS-R98 severity score at baseline for delirium. Cutoff scores for the DRS-R98 severity scale at baseline were determined using receiver-operator characteristic (ROC) analyses to determine the Youden Index when comparing patients developing delirium with patients without delirium. Sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio (sensitivity/1-specificity), and negative likelihood ratio (1-sensitivity/specificity) were also calculated. All statistical tests were two-tailed. Values of P b 0.05 were regarded as statistically significant. Table 1 shows baseline characteristics. There were no significant differences in the mean age, the rate of previous delirium, the rate of dementia, and the mean CDR score between patients developing delirium and patients without delirium. The numbers of patients with Alzheimer's disease among those developing delirium and those without delirium were 1 (11%) and 2 (10%), respectively. There were no significant differences in admission diagnoses between patients developing delirium and patients without delirium, although stroke, infection, fracture, and heart failure are risk factors for delirium (Michaud et al., 2007) .
Results

Baseline characteristics
A total of 5 of 12 patients admitted to ICUs developed delirium, whereas 4 of 17 patients admitted to regular acute wards developed delirium (42% vs. 24%, respectively, relative risk = 1.77, P = 0.42).
The DRS-R98 severity score at baseline
The mean DRS-R98 severity score of patients developing delirium was significantly higher than that of patients without delirium (7.4 [SD 4.7] vs. 3.6 [4.5], respectively, P = 0.044, Table 1 ). Therefore, we assessed the predictive value of the DRS-R98 severity score at baseline for delirium. Cutoff scores for the DRS-R98 severity score at baseline were determined using receiver-operator characteristic (ROC) analyses to determine the Youden Index when comparing patients developing delirium with patients without delirium.
According to the value of the Youden Index, the best cutoff score for the DRS-R98 severity score at baseline was 4/5. At the score, sensitivity of 78%, specificity 75%, positive predictive value 58%, negative predictive value 88%, positive likelihood ratio 3.12, and negative likelihood ratio 0.29, indicate that the predictive value of the DRS-R98 severity score at baseline for delirium is not so high.
The CDR score at baseline
We examined if CDR score of 0.5 or more, which indicates coexistence of dementia, predicted the development of delirium. The percentage of patients developing delirium with a CDR score of 0.5 or more at baseline was significantly higher than that of patients without delirium (67% vs. 25%, respectively, relative risk, 2.67, P = 0.048). The sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio for use of the parameter for comparison of patients developing delirium with patients without delirium were 67%, 75%, 55%, 83%, 2.67, and 0.44, respectively.
3.4. Change in blood NK cell activity between the first and second mornings after admission
There was no significant difference between the groups in blood NK cell activity on the first morning after admission (Table 1) . However, the mean change in blood NK cell activity on the second morning, compared to the first morning, in patients developing delirium was significantly greater than that in patients without delirium (6.0% [SD 8.4 ] vs. −1.4% [9.0], respectively, t = 2.10, P = 0.045). Significant difference between the groups was still found after adjusting for age, the history of previous delirium, and the CDR score, which are well-known risk factors of delirium (Litaker et al., 2001 ) (F = 6.63, P = 0.017) (Fig. 1) . Of note is that 8 of 9 (89%) patients developing delirium had increased blood NK cell activity, as did only 8 of 20 (40%) patients without delirium, giving measurement of this parameter, for distinguishing the two groups, a sensitivity of 89%, specificity 60%, positive predictive value 50%, negative predictive value 92%, positive likelihood ratio 2.22, and negative likelihood ratio 0.19.
Change in blood IL-1β between the first and second mornings after admission
There was no significant difference between the groups in blood IL-1β on the first morning after admission (Table 1 ). The significant difference in the mean change in blood IL-1β on the second morning from the first morning between patients developing delirium and patients without 
The combination of the DRS-R98 severity score at baseline and the change in NK cell activity
Of particular note is the fact that the percentage of patients developing delirium who had both a DRS-R98 severity score of 5 or more at baseline and an increase in NK cell activity on the second morning compared to the first morning after admission was significantly higher than that of patients without delirium (78% vs. 10%, respectively, relative risk, 7.78, P = 0.0007) (Fig. 1) . The sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio for use of these two parameters combined for comparison of patients developing delirium with patients without delirium were 78%, 90%, 78%, 90%, 7.80 and 0.24, respectively.
The combination of the CDR score at baseline and the change in NK cell activity
The percentage of patients developing delirium who had both a CDR score of 0.5 or more at baseline and an increase in NK cell activity on the second morning compared to the first morning after admission was significantly higher than that of patients without delirium (67% vs. 10%, respectively, relative risk, 6.67, P = 0.0039). The sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio for use of these two parameters combined for comparison of patients developing delirium with patients without delirium were 67%, 90%, 75%, 86%, 6.67 and 0.37, respectively.
Discussion
Inflammatory response and delirium
An increased inflammatory response has been proposed to be involved in delirium pathophysiology, as have dysfunction of neurotransmitters, decreased oxidative metabolism, abnormal signal transduction, changes in blood-brain barrier permeability, and endocrine abnormalities (Cerejeira et al., 2010) . In animal studies, there is compelling evidence that acute peripheral inflammatory stimulation associated with functional and molecular changes in the blood-brain barrier (Sparkman et al., 2006 ) induces recruitment and infiltration of blood-derived leucocytes into brain tissue (Hofer et al., 2008; Nishioku et al., 2009; Semmler et al., 2005) , activation of brain parenchymal cells, and expression of proinflammatory cytokines and inflammatory mediators in the central nervous system (Cerejeira et al., 2010) . However, there is inconsistency between findings in clinical studies about blood levels of cytokines and delirium. One has shown higher blood levels of IL-6 and IL-8 in patients with vs. without post-operative delirium (van Munster et al., 2008) , but another has shown no relationship between blood IL-6, IL-1β or TNF-α and delirium in elderly medical inpatients . Furthermore, there has been little evidence with respect to delirium prediction other than IGF-1 (Adamis and Meagher, 2011) . Therefore, the present finding suggesting the association between increasing blood NK cell activity and risk of delirium may be remarkable.
To our knowledge, there is only one previously reported study regarding NK cell activity and delirium, which showed no difference in blood NK cell activity before surgery between 11 patients with postoperative delirium and 15 patients without postoperative delirium (Nakamura et al., 2001 ). However, blood NK cell activity was measured only once in that study, so whether NK cell activity was ascending or descending was not known. In the current study, blood NK cell activity was measured twice at a 24 h interval, so whether NK cell activity was ascending or descending was determined for each patient.
Although inflammatory blood markers can be abnormal in Alzheimer's disease (Jadidi-Niaragh et al., 2012) , the numbers in the current study were only 1 (11%) and 2 (10%) among the patients developing delirium and the patients without delirium, respectively. Therefore, the effect of their inclusion on the present findings may have been small. In addition, inflammatory blood markers in Alzheimer's disease may be more general markers of neurodegeneration without a strong relationship to the more specific behavioral and psychological symptoms of dementia. Such markers may not have affected results of the 2-time-point observation performed at a 24-h interval in this study.
As NK cells can be swiftly mobilized by danger signals and are among the earliest arrivals at target organs of disease (Shi et al., 2011) , a change in NK cell activity might be suitable as an early indication of an acute disease such as delirium. In addition, the association between ascending blood NK cell activity and occurrence of delirium demonstrated in this study may support an inflammatory process as an etiology of delirium, as NK cells have been shown to migrate to the inflamed central nervous system (Shi et al., 2011) . Macdonald et al. (2007) reported first that high levels of C-reactive protein (CRP) independently predicted the incidence of delirium, and that a higher initial Mini-Mental State Examination score and low CRP predicted the recovery from delirium at any time during hospitalization for patients with delirium. Since then, attention has been paid to the association between CRP and delirium. Recently, high baseline inflammatory biomarkers such as procalcitonin and CRP reportedly predicted prolonged periods of acute brain dysfunction, implicating inflammation as an important mechanism in the pathophysiology of delirium and coma in mechanically ventilated patients, irrespective of whether patients had sepsis (McGrane et al., 2011) . These reports suggest a possible similar mechanism where a general indicator of inflammatory response is associated with delirium.
The present study showed no change in blood IL-1β prior to the onset of delirium. This is consistent with a previous clinical study that showed no relationship between blood IL-6, IL-1β or TNF-α and delirium in elderly medical inpatients . Cytokine concentration can vary considerably over time and can be influenced by an individual's genetic background, comorbid systemic inflammatory processes, usage of anti-inflammatory drugs, and exposure to environmental factors (Flirski and Sobow, 2005) . Nevertheless, blood IL-1β did not change just before developing delirium, in contrast to development of agitation as a behavioral and psychological symptom of Alzheimer disease, as previously reported (Higuchi et al., 2010; Honma et al., in press ). The reason for this difference between delirium and Alzheimer disease is unclear. An explanation may be that blood Change in blood NK cell activity on the second morning compared to the first morning after admission. The mean change in blood NK cell activity on the second morning from the first morning after admission of patients developing delirium was significantly greater than that of patients without delirium after adjusting for age, the history of previous delirium, and the Clinical Dementia Rating score (6.0% [SD 8.4] vs. −1.4% [9.0], respectively, F = 6.63, P = 0.017).
Cases with the DRS-R98 severity score of 5 or more at baseline, Cases with the DRS-R98 severity score of 4 or less at baseline. had not yet been affected just before developing delirium despite increasing blood NK cell activity, as delirium is much more acute-onset than the behavioral and psychological symptoms of dementia (BPSD). Another explanation may be that the etiology of delirium is associated with increasing NK cell activity, but not associated with a change in an inflammatory cytokine such as IL-1β, in contrast to BPSD. Third, a change in blood IL-1β may not necessarily reflect IL-1β levels in the central nervous system.
Clinical relevance of the change in NK cell activity for delirium prediction
Monitoring patients at risk of delirium for increasing blood NK cell activity more closely may have a mild effect, as the positive likelihood ratio seen in this study was 2.22. In contrast, the negative likelihood ratio, at 0.19, for the change in NK cell activity is moderate for a negative test, and suggests that patients without an increase in NK cell activity are less likely to develop delirium. However, such patients definitely should continue to be monitored regularly, as delirium can actually develop even in these individuals. With respect to the monitoring of patients, therefore, a change in NK cell activity may be of only modest usefulness.
Considering the positive and negative likelihood ratios for comparison of patients developing delirium with patients without delirium, each of two indicators (i.e. the DRS-R98 severity score of 5 or more at baseline and an increase in NK cell activity on the second morning from the first morning after admission) was a mild positive predictor and a mild or moderate negative predictor. However, the combination of these predictors had marked synergistic effects, resulting in a positive likelihood ratio of 7.80 and a negative likelihood ratio of 0.24. These values suggest that the combination of the two indicators is a moderate positive predictor of delirium rather than a negative predictor.
With respect to the predictive value for delirium, the CDR score at baseline was inferior to the DRS-R98 severity score at baseline (positive likelihood ratio: 2.67 vs. 3.12, respectively; negative likelihood ratio: 0.44 vs. 0.29, respectively). Similarly, the combination of the CDR score at baseline and the change in NK cell activity was inferior to the combination of the DRS-R98 severity score at baseline and the change in NK cell activity (positive likelihood ratio: 6.67 vs. 7.80, respectively; negative likelihood ratio: 0.37 vs. 0.24, respectively). However, the difference in the predictive value for delirium between the two parameters was small, and the CDR is simpler than the DRS-R98. Therefore, the combination of the CDR score at baseline and the change in NK cell activity might be worth investigating as well as the combination of the DRS-R98 severity score at baseline and the change in NK cell activity in future studies.
From the perspective of pharmacological delirium prevention, a possibility is raised as the preventive effects of melatonin (Al-Aama et al., 2011) and its analogue ramelteon (Hatta et al., in press) on delirium have been demonstrated in placebo controlled randomized trials. Nether melatonin nor ramelteon has serious side effects, so that their use might not be harmful. Therefore, using melatonin and its analogue might be justified for patients having both the DRS-R98 severity score of 5 or more at baseline and increasing blood NK cell activity, as the combination of both indicators seems to be a moderate positive predictor. Thus, the present findings may lead to a pharmacological strategy for delirium prevention.
Strength and limitation
One strength of our study was the prospective design. The change in NK cell activity is predictive and is not the baseline measure, which is an important difference from other predictor reports. Another strength was that all participants were emergency cases requiring admission, mirroring real clinical practice. One limitation was that sample size was relatively small. It is possible that the number of patients was too small to detect a sufficiently high positive likelihood ratio or a sufficiently low negative likelihood ratio. Further studies including larger numbers of patients are needed to know if more robust results would be observed.
Conclusion
Increased blood NK cell activity is a mild positive predictor of delirium whereas no increased blood NK cell activity is a moderate negative predictor of delirium. The combination of two predictors, a DRS-R98 severity score of 5 or more at baseline and increased NK cell activity, is a moderate positive predictor of delirium. Further studies including larger numbers of patients are needed to justify use of drugs having preventive effects on delirium and no harmful side effects by patients having both predictive criteria prior to developing delirium.
